Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ADT Inc | Fawad Ahmad | EVP, Chief Oper and Cust. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 1,702 | 304,036 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Kimberly Miller | EVP, CMO & Comm. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 416 | 56,401 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Daniel J. Houston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 101,376 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Thomas M. Gartland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 51,746 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Matthew E. Winter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 152,789 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Tracey R. Griffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 153,560 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Sigal Zarmi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 108,018 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Paul Joseph Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 44,792 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Danielle Tiedt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 64,926 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Suzanne Yoon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 209 | 60,430 (0%) | 0% | 0 | Common Stock | |
| ADT Inc | Todd Dernberger | EVP and Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 100 | 45,494 (0%) | 0% | 0 | Common Stock | |
| Candel Therapeutics Inc | Mark E. Sims | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2026 | 285,000 | 285,000 | - | - | Stock Option (Right to Buy) | |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 149.26 per share. | 06 Jul 2026 | 1,317 | 20,296 (0%) | 0% | 149.3 | 196,575 | Common Stock |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 147.92 per share. | 06 Jul 2026 | 265 | 21,613 (0%) | 0% | 147.9 | 39,199 | Common Stock |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 145.84 per share. | 06 Jul 2026 | 227 | 22,013 (0%) | 0% | 145.8 | 33,106 | Common Stock |
| Mastercard | Sandra A. Arkell | Controller | Sale of securities on an exchange or to another person at price $ 540.00 per share. | 06 Jul 2026 | 200 | 3,321 (0%) | 0% | 540 | 108,000 | Class A Common Stock |
| Mastercard | Sandra A. Arkell | Controller | Sale of securities on an exchange or to another person at price $ 540.00 per share. | 06 Jul 2026 | 200 | 3,121 (0%) | 0% | 540 | 108,000 | Class A Common Stock |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 146.90 per share. | 06 Jul 2026 | 135 | 21,878 (0%) | 0% | 146.9 | 19,832 | Common Stock |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 143.46 per share. | 06 Jul 2026 | 48 | 22,240 (0%) | 0% | 143.5 | 6,886 | Common Stock |
| WEX Inc | Robert Deshaies | COO, Benefits | Sale of securities on an exchange or to another person at price $ 149.75 per share. | 06 Jul 2026 | 8 | 20,288 (0%) | 0% | 149.8 | 1,198 | Common Stock |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. | 02 Jul 2026 | 2,027 | 20,431 (0%) | 0% | 109.8 | 222,605 | Class A Common Stock |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 2,027 | 2,028 | - | - | Employee Stock Option (Right to Buy) | |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 360.00 per share. | 02 Jul 2026 | 2,027 | 18,404 (0%) | 0% | 360 | 729,720 | Class A Common Stock |
| Evolent Health Inc (Class A) | Seth Blackley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 446,102 | 1,283,064 (1%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Daniel McCarthy | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 302,585 | 725,607 (0%) | 0% | 0 | Class A Common Stock | |
| QXO Inc | Alec C. Covington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 150,368 | 150,368 (3%) | 3% | - | Common Stock, $0.00001 par value | |
| Evolent Health Inc (Class A) | Jonathan D. Weinberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 43,055 | 287,567 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Aammaad Shams | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 28,790 | 95,637 (0%) | 0% | 0 | Class A Common Stock | |
| Aeluma Inc | Jonathan Klamkin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2026 | 20,000 | 22,403 | - | 0 | Common Stock | |
| Aeluma Inc | Jonathan Klamkin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2026 | 20,000 | 1,346,995 | - | 0 | Common Stock | |
| Aeluma Inc | Jonathan Klamkin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 01 Jul 2026 | 19,900 | 2,503 | - | 21.1 | 419,512 | Common Stock |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 16.88 per share. | 01 Jul 2026 | 18,750 | 185,008 | - | 16.9 | 316,448 | Class A Common Stock |
| Mastercard | Edward G. McLaughlin | President & CTO, MA Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 14,260 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mastercard | Edward G. McLaughlin | President & CTO, MA Tech | Sale of securities on an exchange or to another person at price $ 525.19 per share. | 01 Jul 2026 | 14,260 | 38,739 (0%) | 0% | 525.2 | 7,489,187 | Class A Common Stock |
| Mastercard | Edward G. McLaughlin | President & CTO, MA Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.49 per share. | 01 Jul 2026 | 14,260 | 52,999 (0%) | 0% | 173.5 | 2,473,967 | Class A Common Stock |
| CoreCivic Inc | Cole G. Carter | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 30.46 per share. | 01 Jul 2026 | 12,500 | 203,383 (0%) | 0% | 30.5 | 380,750 | Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. | 01 Jul 2026 | 10,490 | 25,664 (0%) | 0% | 109.8 | 1,152,012 | Class A Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 10,490 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Evolent Health Inc (Class A) | Seth Blackley | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 01 Jul 2026 | 10,297 | 1,272,767 (1%) | 0% | 5.7 | 59,105 | Class A Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 343.88 per share. | 01 Jul 2026 | 8,852 | 16,812 (0%) | 0% | 343.9 | 3,044,069 | Class A Common Stock |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Sale of securities on an exchange or to another person at price $ 525.00 per share. | 01 Jul 2026 | 4,828 | 16,429 (0%) | 0% | 525 | 2,534,700 | Class A Common Stock |
| Evolent Health Inc (Class A) | Daniel McCarthy | PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 01 Jul 2026 | 4,582 | 721,025 (0%) | 0% | 5.7 | 26,301 | Class A Common Stock |
| Healthcare Services Grp Inc | Andrew M. Brophy | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 4,381 | 19,922 (0%) | 0% | 0 | Common Stock | |
| QXO Inc | Alec C. Covington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 3,494 | 153,862 (3%) | 0% | - | Common Stock, $0.00001 par value | |
| Stagwell Inc (Class A) | Eli Samaha | Director | Grant, award, or other acquisition of securities at price $ 7.43 per share. | 01 Jul 2026 | 2,691 | 170,764 | - | 7.4 | 19,994 | Class A Common Stock |
| Evolent Health Inc (Class A) | Jonathan D. Weinberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 01 Jul 2026 | 2,650 | 284,917 (0%) | 0% | 5.7 | 15,211 | Class A Common Stock |
| Stagwell Inc (Class A) | Vaughan A. Brandt | Director | Grant, award, or other acquisition of securities at price $ 7.43 per share. | 01 Jul 2026 | 2,355 | 220,504 | - | 7.4 | 17,498 | Class A Common Stock |
| ICF Intl Inc | Caroline Angoorly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 4,441 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Hans Wildenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 26,531 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Srikant M. Datar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 5,998 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Scott B. Salmirs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 11,650 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Randall A. Mehl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 23,851 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Marilyn Crouther | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 10,859 (0%) | 0% | 0 | Common | |
| ICF Intl Inc | Michelle A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 2,277 | 8,498 (0%) | 0% | 0 | Common | |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 2,000 | 1,977 | - | - | Employee Stock Option (right to buy) | |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 290.25 per share. | 01 Jul 2026 | 2,000 | 21,257 (0%) | 0% | 290.3 | 580,500 | Class A Common Stock |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,977 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Sale of securities on an exchange or to another person at price $ 529.73 per share. | 01 Jul 2026 | 1,977 | 16,429 (0%) | 0% | 529.7 | 1,047,276 | Class A Common Stock |
| Mastercard | Raj Seshadri | Chief Commercial Pmts Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 290.25 per share. | 01 Jul 2026 | 1,977 | 18,406 (0%) | 0% | 290.2 | 573,824 | Class A Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 344.55 per share. | 01 Jul 2026 | 1,638 | 15,174 (0%) | 0% | 344.5 | 564,365 | Class A Common Stock |
| Alx Oncology Holdings Inc | Shelly Pinto | SVP, FINANCE AND CAO | Sale of securities on an exchange or to another person at price $ 2.04 per share. | 01 Jul 2026 | 1,404 | 88,401 | - | 2.0 | 2,864 | Common Stock |
| International Money Express Inc | Michael Purcell | Director | Grant, award, or other acquisition of securities at price $ 14.54 per share. | 01 Jul 2026 | 1,075 | 87,696 (0%) | 0% | 14.5 | 15,631 | Common Stock |
| Atomera Inc | Robert Mears | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 01 Jul 2026 | 1,000 | 271,715 (1%) | 0% | 8.4 | 8,400 | Common Stock |
| Huron Consulting Grp Inc | Shoshana M. Vernick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 934 | 934 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | David Orr | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.54 per share. | 01 Jul 2026 | 539 | 36,034 (0%) | 0% | 44.5 | 24,007 | Common Stock |
| Brink`s Co. | Michael J. Herling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 171 | 19,509 (0%) | 0% | 0 | Common Stock | |
| Brink`s Co. | Ian D. Clough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 167 | 31,150 (0%) | 0% | 0 | Common Stock | |
| Brink`s Co. | Paul G. Boynton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 158 | 10,998 | - | - | Plan Units | |
| International Money Express Inc | Laura I. Maydon | Director | Grant, award, or other acquisition of securities at price $ 14.54 per share. | 01 Jul 2026 | 138 | 48,500 (0%) | 0% | 14.5 | 2,007 | Common Stock |
| Aeluma Inc | Jonathan Klamkin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 01 Jul 2026 | 100 | 2,403 | - | 21.6 | 2,156 | Common Stock |
| Gaotu Techedu Inc (ADR) | Hao Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 24,000 | 24,000 | - | - | Restricted Share Units | |
| Absci Corp | Mary T. Szela | Director | Purchase of securities on an exchange or from another person at price $ 11.54 per share. | 30 Jun 2026 | 12,900 | 21,300 | - | 11.5 | 148,866 | Common Stock |
| Acacia Research Corp | Gavin T. Molinelli | Director | Grant, award, or other acquisition of securities at price $ 4.66 per share. | 30 Jun 2026 | 6,438 | 205,966 (0%) | 0% | 4.7 | 30,001 | Common Stock, par value $0.001 |
| Brink`s Co. | Elizabeth A. Galloway | EVP and CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.49 per share. | 30 Jun 2026 | 3,240 | 33,795 (0%) | 0% | 94.5 | 306,148 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 2,199 | 2,199 | - | - | Stock Option (Right to Buy) | |
| BrightView Holdings Inc | Jane Okun Bomba | Director | Grant, award, or other acquisition of securities at price $ 14.17 per share. | 30 Jun 2026 | 1,852 | 135,895 (0%) | 0% | 14.2 | 26,243 | Common Stock |
| BrightView Holdings Inc | Mara E. Swan | Director | Grant, award, or other acquisition of securities at price $ 14.17 per share. | 30 Jun 2026 | 1,852 | 132,976 (0%) | 0% | 14.2 | 26,243 | Common Stock |
| BrightView Holdings Inc | William L. Cornog | Director | Grant, award, or other acquisition of securities at price $ 14.17 per share. | 30 Jun 2026 | 1,614 | 81,000 (0%) | 0% | 14.2 | 22,870 | Common Stock |
| Candel Therapeutics Inc | Joseph C. Papa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 1,331 | 1,331 | - | - | Stock Option (Right to Buy) | |
| Fiserv | Gordon M. Nixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 892 | 1,677 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Gary S. Shedlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 791 | 1,486 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Ajei S. Gopal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 765 | 3,044 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Lance M. Fritz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 765 | 3,231 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Wafaa Mamilli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 765 | 2,640 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Henrique Manuel Drummond Borges Cirne De Castro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 663 | 6,840 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Celine S. Dufetel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 663 | 1,246 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Harry F. DiSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 663 | 8,645 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Charlotte B. Yarkoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 663 | 3,083 | - | - | Deferred Compensation Notional Units | |
| Fiserv | Stephanie E. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 663 | 1,246 | - | - | Deferred Compensation Notional Units | |
| Healthcare Services Grp Inc | Kurt Simmons | Director | Grant, award, or other acquisition of securities at price $ 24.56 per share. | 30 Jun 2026 | 611 | 30,770 (0%) | 0% | 24.6 | 15,006 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 41.24 per share. | 30 Jun 2026 | 607 | 39,770 (0%) | 0% | 41.2 | 25,033 | Common Stock |
| Laureate Education Inc | George Munoz | Director | Grant, award, or other acquisition of securities at price $ 36.32 per share. | 30 Jun 2026 | 585 | 122,563 | - | 36.3 | 21,247 | Common Stock |
| Candel Therapeutics Inc | Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 381 | 381 | - | - | Stock Option (Right to Buy) | |
| Healthcare Services Grp Inc | Laura Grant | Director | Grant, award, or other acquisition of securities at price $ 24.56 per share. | 30 Jun 2026 | 306 | 18,314 (0%) | 0% | 24.6 | 7,515 | Common Stock |
| ICF Intl Inc | John Wasson | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 70.06 per share. | 30 Jun 2026 | 279 | 21,582 (0%) | 0% | 70.1 | 19,547 | Common |
| Booz Allen Hamilton Holding Corp (Class A) | Joshua Petty | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.67 per share. | 30 Jun 2026 | 244 | 10,038 (0%) | 0% | 60.7 | 14,803 | Class A Common Stock |
| Equifax | Robert D. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 221 | 2,710 | - | - | Phantom Stock Units | |
| WEX Inc | James R. Groch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 186 | 18,143 (0%) | 0% | - | Common Stock | |
| Brink`s Co. | Richard Mark Eubanks | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 126 | 47,105 | - | - | Program Units | |
| Healthcare Services Grp Inc | Thomas G. Whalen | Director | Grant, award, or other acquisition of securities at price $ 24.56 per share. | 30 Jun 2026 | 102 | 5,357 (0%) | 0% | 24.6 | 2,505 | Common Stock |
| WEX Inc | Kurt Patrick Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 79 | 379 (0%) | 0% | - | Common Stock | |
| WEX Inc | Lauren Taylor Wolfe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 79 | 1,707,332 (3%) | 0% | - | Common Stock | |
| Brink`s Co. | Kurt B. McMaken | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 62 | 5,496 | - | - | Program Units | |
| Brink`s Co. | Guillermo Eduardo Peschard Mijares | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 60 | 970 | - | - | Program Units | |
| Brink`s Co. | Elizabeth A. Galloway | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 46 | 2,983 | - | - | Program Units | |
| Brink`s Co. | Kristen Williams Cook | EVP & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 45 | 349 | - | - | Program Units | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 36 | 32,825 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Brian T Carley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 36 | 71 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Robert O. Kraft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 33 | 955 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Robert O. Kraft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 33 | 64 | - | - | Restricted Stock Unit | |
| Medpace Holdings Inc | Cornelius P. McCarthy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 28 | 10,352 (0%) | 0% | - | Common Stock | |
| Medpace Holdings Inc | Cornelius P. McCarthy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 28 | 56 | - | - | Restricted Stock Unit | |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 865,112 | 10,281,486 | - | - | American Depositary Shares | |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 330,072 | 11,495,788 | - | - | American Depositary Shares | |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 169,928 | 11,325,860 | - | - | American Depositary Shares | |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 79,180 | 11,246,680 | - | - | American Depositary Shares | |
| Charles River Labs | James C. Foster | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 29 Jun 2026 | 75,000 | 31,596 (0%) | 0% | 225 | 16,875,000 | Common Stock |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 50,082 | 11,146,598 | - | - | American Depositary Shares | |
| Silence Therapeutics PLC (ADR) | Richard Ian Griffiths | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Jun 2026 | 50,000 | 11,196,680 | - | - | American Depositary Shares | |
| Universal Technical Institute Inc | Jerome A. Grant | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.63 per share. | 29 Jun 2026 | 48,961 | 335,715 (1%) | 0% | 41.6 | 2,038,217 | Common Stock, $0.0001 par value |
| Universal Technical Institute Inc | Jerome A. Grant | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.15 per share. | 29 Jun 2026 | 45,539 | 384,676 (1%) | 0% | 41.2 | 1,874,089 | Common Stock, $0.0001 par value |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.06 per share. | 29 Jun 2026 | 23,447 | 77,362 | - | 10.1 | 235,769 | Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2026 | 20,970 | 10,490 | - | - | Employee Stock Option (Right to Buy) | |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 340.25 per share. | 29 Jun 2026 | 20,970 | 15,174 (0%) | 0% | 340.2 | 7,134,967 | Class A Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.82 per share. | 29 Jun 2026 | 20,970 | 36,144 (0%) | 0% | 109.8 | 2,302,925 | Class A Common Stock |
| Remitly Global Inc | Joshua Hug | Director | Sale of securities on an exchange or to another person at price $ 22.97 per share. | 29 Jun 2026 | 16,800 | 3,385,457 | - | 23.0 | 385,896 | Common Stock |
| Remitly Global Inc | Joshua Hug | Director | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 29 Jun 2026 | 16,800 | 3,368,657 | - | 22.5 | 378,504 | Common Stock |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 29 Jun 2026 | 7,000 | 83,865 | - | 10.0 | 70,151 | Common Stock |
| Virco Manufacturing Corp | Douglas A. Virtue | Director, Executive Vice President | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 29 Jun 2026 | 1,400 | 880,580 (5%) | 0% | 6 | 8,400 | Common Stock $.01 par value |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.